Neuroprotective effects of Go-sha-jinki-Gan in a Parkinson's disease model
Project/Area Number |
17K09299
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General internal medicine(including psychosomatic medicine)
|
Research Institution | Osaka University |
Principal Investigator |
Baba Kousuke 大阪大学, 医学系研究科, 特任講師(常勤) (90750159)
|
Project Period (FY) |
2017-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 神経疾患 / 牛車腎気丸 / 神経炎症 / 漢方薬 / 中枢神経 / パーキンソン病 / 実験的脊髄炎 / 実験的自己免疫性脊髄炎 / 実験的自己免疫性脊髄炎モデル / 漢方 / 神経保護 |
Outline of Final Research Achievements |
We examined the anti-neuroinflammatory effects of Go-sha-jinki-Gan (GJG), a herbal medicine used in clinical practice, using a model of central nervous system disease. Using two animal models with different pathological mechanisms, a drug-induced Parkinson's disease model and a experimental autoimmune myelitis model, we confirmed biochemically and pathologically that GJG suppresses the expression of the proinflammatory cytokine TNFα by inhibiting p38 phosphorylation, and then inhibits the activation and aggregation of microglia and astrocytes. These results indicate that GJG inhibits neuroinflammation in the central nervous system by suppressing the phosphorylation of p38 in microglia through oral administration. These results were published in the journal Neurotherapeutics.
|
Academic Significance and Societal Importance of the Research Achievements |
これまで臨床現場で使用されてきた牛車腎気丸(GJG)が神経障害に効果を有することは経験的に知られてきた。本研究でその機序を生化学的に明らかにしすることで科学的な裏付けが示す事が出来たと考える。また、今回の研究成果から経口投与で中枢神経系での炎症反応を抑制することが示され、本剤の臨床応用の可能性を拡げたと考える。
|
Report
(5 results)
Research Products
(6 results)
-
[Journal Article] Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System2020
Author(s)
Shiying Jiang, Kousuke Baba, Tatsusada Okuno, Makoto Kinoshita, Chi-Jing Choong, Hideki Hayakawa, Hiroshi Sakiyama, Kensuke Ikenaka, Seiichi Nagano, Tsutomu Sasaki, Munehisa Shimamura, Yoshitaka Nagai, Keisuke Hagihara, Hideki Mochizuki
-
Journal Title
Neurotherapeutics
Volume: 17
Issue: 1
Pages: 1-14
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Presentation] GO-SHA-JINKI-GAN (GJG) Palliates Progression of EAE Mice by Anti-inflammatory Mechanism2018
Author(s)
Shiying Jiang, Kousuke Baba, Tatsusada Okuno, Hideki Hayakawa, Chiharu Shiomoto, Kensuke Ikenaka, Tsutomu Sasaki, Seiichi Nagano, Yoshitaka Nagai, Keisuke Hagihara, Hideki Mochizuki
Organizer
第59回日本神経学会学術大会
Related Report
-
[Presentation] GO-SHA-JINKI-GAN (GJG) Palliates Inflammation In Experimental Autoimmune Encephalomyelitis (EAE) Mice2017
Author(s)
Shiying Jiang, Kousuke Baba, Tatsusada Okuno, Hideki Hayakawa, Chiharu Shiomoto, Kensuke Ikenaka, Tsutomu Sasaki, Seiichi Nagano, Yoshitaka Nagai, Keisuke Hagihara, Hideki Mochizuki
Organizer
XXIII World Congress of Neurology (WCN 2017), Kyoto, Japan
Related Report
Int'l Joint Research